• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic assisted hepatic resection for hepatocellular carcinoma in patients with severely-impaired hepatic function

Laparoscopic assisted hepatic resection for hepatocellular carcinoma in patients with severely-impaired hepatic function

Background and Objectives: Laparoscopic assisted hepatic resection (LAHR) is one of the newly-developed surgical procedures, and requires highly specialized competencies of surgeons for coping with operative bleeding and other complicated difficulties caused by impaired hepatic function. We reviewed our experiences in the LAHR to evaluate whether it was safe and feasible for the treatment of hepatocellular carcinoma (HCC) in patients with severely-impaired hepatic function.
Methods and Procedures: We performed LAHR for HCC in 7 patients from December 2006 to July 2007. The operative procedures were completed by one surgeon experienced in both the conventional hepatic surgery and the advanced laparoscopic surgery. In the procedures of LAHR, the liver parenchyma was transected with newly-developed surgical devices such as microwave coagulators, ultrasonic dissectors, laparoscopic coagulation shears, bipolar electrocoagulations, and endolinear staplers. In the 7 cases, age, sex, preoperative hepatic function, operative procedures, operation time, intraoperative blood loss, postoperative complications, mortality and postoperative hospital stay were retrospectively evaluated.
Results: The seven patients consisted of 6 male and 1 female; mean age, 67 years. All the patients were referred for HCC accompanied with cirrhosis. According to the Child-Pugh score, 2 patients were classified into Class B and 5 patients were classified into Class A. Ascites was identified preoperatively in 5 patients. The mean indocyanine green dye retention at 15 minutes (ICG-R15) value was 32.8% (range, 15.4- 56.3%). The mean tumor size was 2.8 cm (range, 1.5-3.5 cm). Partial resection of the hepatic segment (S2, S3, S6, or S8) was performed in five patients, and lateral segmentectomy was performed in two. Radiofrequency ablation was performed in 2 patients, and partial gastrectomy was performed in 1 patient. The procedures of LAHR were completed and consequently, conversion to laparotomy was not required in all the cases. The mean operation time was 247min (range, 190-345 min). The mean blood loss was 115 ml (range, 5-350 ml), and no blood transfusion was required. The mean postoperative hospital stay was 7.3 days (range, 4–11 days). No postoperative complications or death were identified.
Conclusions: Laparoscopic assisted hepatic resection was evaluated as a safe and feasible option for the treatment of hepatocellular carcinoma in patients with severely-impaired hepatic function when performed by experienced surgeons.


Session: Poster

Program Number: P311

View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search